The Cigna Group Market Risk Benefit Increase Decrease From Other Assumption
The Cigna Group (CI) reported Market Risk Benefit Increase Decrease From Other Assumption of -$17.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Insurance › Market Risk Benefit, after Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change › Market Risk Benefit, after Increase (Decrease) from Instrument-Specific Credit Risk, Alternative
us-gaap:MarketRiskBenefitIncreaseDecreaseFromOtherAssumption · last filed 2026-02-26
- The Cigna Group market risk benefit increase decrease from other assumption for the quarter ending 2025-12-31 was $0.00.
- The Cigna Group market risk benefit increase decrease from other assumption for the quarter ending 2024-12-31 was $0.00.
- The Cigna Group market risk benefit increase decrease from other assumption for the quarter ending 2024-09-30 was $37.00M, a 131.25% increase year-over-year.
- The Cigna Group market risk benefit increase decrease from other assumption for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- The Cigna Group market risk benefit increase decrease from other assumption for fiscal 2025 was -$17.00M, a 145.95% decline from fiscal 2024.
- The Cigna Group market risk benefit increase decrease from other assumption for fiscal 2024 was $37.00M.
- The Cigna Group market risk benefit increase decrease from other assumption for fiscal 2023 was -$16.00M, a 124.62% decline from fiscal 2022.
- The Cigna Group market risk benefit increase decrease from other assumption for fiscal 2022 was $65.00M.
| Period end | Market Risk Benefit Increase Decrease From Other Assumption 3 month | Market Risk Benefit Increase Decrease From Other Assumption 6 month | Market Risk Benefit Increase Decrease From Other Assumption 9 month | Market Risk Benefit Increase Decrease From Other Assumption 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$17.00M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$17.00M 10-Q · filed 2025-10-30 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $37.00M derived: sum of 2 quarters · filed 2026-02-26 | $37.00M derived: sum of 3 quarters · filed 2026-02-26 | $37.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $37.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $37.00M derived: sum of 2 quarters · filed 2025-10-30 | $37.00M 10-Q · filed 2025-10-30 | $37.00M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $16.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $16.00M derived: sum of 3 quarters · filed 2025-02-27 | $17.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $16.00M derived: sum of 2 quarters · filed 2025-02-27 | $17.00M derived: sum of 3 quarters · filed 2025-02-27 | -$16.00M 10-K · filed 2025-02-27 |
| 2023-09-30 | $16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $17.00M derived: sum of 2 quarters · filed 2024-10-31 | -$16.00M 10-Q · filed 2024-10-31 | -$16.00M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$32.00M 10-Q · filed 2024-08-01 | -$32.00M derived: sum of 3 quarters · filed 2024-08-01 | -$6.00M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | -$33.00M 10-Q · filed 2024-05-02 | -$33.00M derived: sum of 2 quarters · filed 2024-05-02 | -$7.00M derived: sum of 3 quarters · filed 2024-05-02 | -$7.00M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $26.00M derived: sum of 2 quarters · filed 2024-02-29 | $26.00M derived: sum of 3 quarters · filed 2024-02-29 | $65.00M 10-K · filed 2024-02-29 |
| 2022-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $26.00M derived: sum of 2 quarters · filed 2023-11-02 | $65.00M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $39.00M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $39.00M 10-Q · filed 2023-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |